Align (ALGN) Stock Forecast, Price Target & Predictions
ALGN Stock Forecast
Align stock forecast is as follows: an average price target of $252.00 (represents a 12.27% upside from ALGN’s last price of $224.45) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.
ALGN Price Target
ALGN Analyst Ratings
Buy
Align Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 24, 2024 | Jonathan Block | Stifel Nicolaus | $275.00 | $207.66 | 32.43% | 22.52% |
Oct 24, 2024 | Jason Bednar | Piper Sandler | $275.00 | $221.06 | 24.40% | 22.52% |
Oct 24, 2024 | Michael Cherny | Leerink Partners | $235.00 | $207.66 | 13.17% | 4.70% |
Oct 24, 2024 | Elizabeth Anderson | Evercore ISI | $250.00 | $207.66 | 20.39% | 11.38% |
Oct 17, 2024 | Jason Bednar | Piper Sandler | $285.00 | $216.05 | 31.91% | 26.98% |
Oct 11, 2024 | Jonathan Block | Stifel Nicolaus | $285.00 | $229.65 | 24.10% | 26.98% |
Oct 10, 2024 | Charles Perron-Piche | Goldman Sachs | $225.00 | $231.04 | -2.62% | 0.25% |
Oct 08, 2024 | Elizabeth Anderson | Evercore ISI | $270.00 | $234.85 | 14.97% | 20.29% |
Jul 25, 2024 | Jason Bednar | Piper Sandler | $315.00 | $226.05 | 39.35% | 40.34% |
Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $325.00 | $251.60 | 29.17% | 44.80% |
Jun 21, 2024 | Jason Bednar | Piper Sandler | $330.00 | $242.61 | 36.02% | 47.03% |
Apr 25, 2024 | Jason Bednar | Piper Sandler | $375.00 | $305.00 | 22.95% | 67.08% |
Apr 25, 2024 | Jeff Johnson | Robert W. Baird | $370.00 | $313.78 | 17.92% | 64.85% |
Apr 18, 2024 | Jonathan Block | Stifel Nicolaus | $400.00 | $300.14 | 33.27% | 78.21% |
Mar 15, 2024 | Jonathan Block | Stifel Nicolaus | $350.00 | $314.35 | 11.34% | 55.94% |
Mar 13, 2024 | Jason Bednar | Piper Sandler | $355.00 | $320.69 | 10.70% | 58.16% |
Sep 09, 2022 | Jason Bednar | Piper Sandler | $340.00 | $257.30 | 32.14% | 51.48% |
Jul 26, 2022 | Jonathan Block | Stifel Nicolaus | $375.00 | $252.07 | 48.77% | 67.08% |
Apr 26, 2022 | UBS | $500.00 | $361.35 | 38.37% | 122.77% | |
Apr 21, 2022 | Piper Sandler | $600.00 | $395.05 | 51.88% | 167.32% | |
Apr 03, 2022 | Brandon Couillard | Jefferies | $635.00 | $446.41 | 42.25% | 182.91% |
Jul 28, 2021 | Richard Newitter | Leerink Partners | $770.00 | $621.87 | 23.82% | 243.06% |
Jul 09, 2021 | Chris Cooley | Stephens | $700.00 | $627.19 | 11.61% | 211.87% |
Jul 08, 2021 | Julien Ouaddour | BNP Paribas | $790.00 | $616.79 | 28.08% | 251.97% |
Align Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 16 |
Avg Price Target | - | - | $307.50 |
Last Closing Price | $224.45 | $224.45 | $224.45 |
Upside/Downside | -100.00% | -100.00% | 37.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 04, 2024 | Needham | Hold | Hold | Hold |
Oct 24, 2024 | Leerink Partners | Market Perform | Market Perform | Hold |
Oct 17, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 10, 2024 | B. Riley Securities | Buy | Initialise | |
Oct 10, 2024 | Goldman Sachs | Neutral | Buy | Initialise |
Oct 10, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
Oct 10, 2024 | Sandler O'Neill | Buy | Buy | Hold |
Oct 10, 2024 | Needham | Hold | Initialise | |
Oct 08, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Sep 13, 2024 | Sandler O'Neill | Buy | Buy | Hold |
Sep 13, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
Sep 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 15, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jul 25, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jul 22, 2024 | Sandler O'Neill | Outperform | Outperform | Hold |
Jul 22, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
Jun 21, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jun 04, 2024 | OTR Global | Positive | Mixed | Downgrade |
May 16, 2024 | Piper Sandler | Overweight | Overweight | Hold |
May 01, 2024 | HSBC | Buy | Buy | Hold |
Apr 25, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Apr 09, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Sep 14, 2023 | Redburn Partners | Neutral | Downgrade | |
Sep 14, 2023 | Jefferies | Buy | Hold | Upgrade |
Sep 14, 2023 | Susquehanna | Positive | Upgrade | |
Apr 19, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Mar 31, 2023 | OTR Global | Positive | Upgrade | |
Feb 03, 2023 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
Feb 03, 2023 | RBC Capital | Sector Perform | Downgrade | |
Feb 03, 2023 | BMO Capital | Market Perform | Downgrade | |
Feb 03, 2023 | Wolfe Research | Peer Perform | Downgrade | |
Feb 03, 2023 | HSBC | Reduce | Downgrade | |
Feb 03, 2023 | Oppenheimer | Perform | Downgrade | |
Feb 03, 2023 | Citigroup | Outperform | Upgrade | |
Feb 02, 2023 | Cowen & Co. | Buy | Buy | Hold |
Feb 02, 2023 | Goldman Sachs | Neutral | Upgrade | |
Sep 09, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Jul 20, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Jun 15, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Apr 28, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Apr 26, 2022 | UBS | Buy | Buy | Hold |
Apr 03, 2022 | Jefferies | Buy | Buy | Hold |
Jul 11, 2021 | Stephens | Overweight | Upgrade |
Align Financial Forecast
Align Revenue Forecast
Quarter
Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $956.73M | $960.21M | $1.00B | $943.15M | $901.51M | $890.35M | $969.55M | $973.22M | $1.03B | $1.02B | $1.01B | $894.77M | $834.52M | $734.14M | $352.31M |
Avg Forecast | $1.49B | $1.44B | $1.39B | $1.14B | $1.11B | $1.15B | $1.10B | $1.07B | $1.04B | $1.08B | $1.04B | $999.51M | $990.05M | $1.04B | $974.53M | $933.67M | $994.48M | $991.34M | $903.21M | $891.81M | $963.76M | $984.66M | $1.00B | $1.02B | $977.81M | $947.35M | $818.18M | $791.05M | $529.26M | $325.21M |
High Forecast | $1.53B | $1.47B | $1.42B | $1.17B | $1.13B | $1.18B | $1.12B | $1.09B | $1.06B | $1.11B | $1.06B | $1.01B | $992.22M | $1.04B | $974.53M | $940.24M | $1.01B | $1.01B | $924.05M | $906.25M | $963.76M | $984.66M | $1.00B | $1.02B | $977.81M | $947.35M | $818.18M | $791.05M | $529.26M | $325.21M |
Low Forecast | $1.44B | $1.39B | $1.34B | $1.10B | $1.07B | $1.11B | $1.06B | $1.03B | $1.00B | $1.04B | $1.00B | $987.96M | $987.87M | $1.04B | $974.53M | $930.08M | $978.38M | $955.55M | $870.60M | $871.76M | $963.76M | $984.66M | $1.00B | $1.02B | $977.81M | $947.35M | $818.18M | $791.05M | $529.26M | $325.21M |
# Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 9 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.97% | 1.01% | 1.04% | 1.01% | 0.92% | 0.98% | 0.97% | 1.01% | 1.04% | 1.07% | 1.09% | 1.05% | 1.39% | 1.08% |
Forecast
Align EBITDA Forecast
Quarter
Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 9 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $171.54M | $166.35M | $171.93M | $133.52M | $135.57M | $143.66M | $188.20M | $198.08M | $220.89M | $289.60M | $294.69M | $287.26M | $239.31M | $209.03M | $-49.95M |
Avg Forecast | $325.15M | $313.90M | $303.04M | $248.13M | $241.47M | $251.32M | $239.05M | $232.19M | $226.26M | $236.18M | $225.61M | $217.80M | $215.74M | $226.12M | $249.40M | $203.45M | $216.70M | $216.02M | $226.72M | $232.22M | $191.66M | $195.81M | $206.11M | $203.50M | $194.45M | $188.39M | $220.42M | $157.31M | $105.25M | $64.67M |
High Forecast | $332.65M | $321.14M | $310.03M | $253.86M | $247.04M | $257.12M | $244.57M | $237.55M | $231.49M | $241.63M | $230.04M | $220.63M | $216.21M | $226.39M | $299.28M | $204.88M | $219.33M | $221.00M | $272.07M | $278.67M | $191.66M | $195.81M | $247.33M | $203.50M | $194.45M | $188.39M | $264.50M | $157.31M | $105.25M | $64.67M |
Low Forecast | $313.41M | $302.56M | $292.09M | $239.18M | $232.75M | $242.25M | $230.42M | $223.81M | $218.09M | $227.66M | $218.98M | $215.28M | $215.26M | $225.86M | $199.52M | $202.67M | $213.19M | $208.22M | $181.38M | $185.78M | $191.66M | $195.81M | $164.89M | $203.50M | $194.45M | $188.39M | $176.34M | $157.31M | $105.25M | $64.67M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.84% | 0.77% | 0.80% | 0.59% | 0.58% | 0.75% | 0.96% | 0.96% | 1.09% | 1.49% | 1.56% | 1.30% | 1.52% | 1.99% | -0.77% |
Forecast
Align Net Income Forecast
Quarter
Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 9 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $124.01M | $121.43M | $111.81M | $87.80M | $41.77M | $72.70M | $112.80M | $134.30M | $190.96M | $180.97M | $199.71M | $200.38M | $158.99M | $139.37M | $-40.60M |
Avg Forecast | $192.80M | $190.54M | $169.96M | $229.08M | $213.68M | $213.79M | $189.84M | $205.26M | $190.12M | $195.57M | $171.12M | $183.59M | $173.02M | $174.66M | $169.09M | $162.66M | $169.13M | $152.12M | $153.72M | $200.76M | $162.48M | $167.58M | $139.74M | $206.19M | $195.30M | $189.84M | $153.75M | $161.01M | $47.79M | $-917.79K |
High Forecast | $198.58M | $196.26M | $175.06M | $235.95M | $220.09M | $220.21M | $195.54M | $211.42M | $195.83M | $201.43M | $189.97M | $186.61M | $173.19M | $175.71M | $202.91M | $166.41M | $172.86M | $156.68M | $184.46M | $240.91M | $162.48M | $167.58M | $167.69M | $206.19M | $195.30M | $189.84M | $184.50M | $161.01M | $47.79M | $-917.79K |
Low Forecast | $183.75M | $181.60M | $161.98M | $218.33M | $203.65M | $203.76M | $180.93M | $195.63M | $181.20M | $186.39M | $161.32M | $179.05M | $172.85M | $173.60M | $135.27M | $158.91M | $166.15M | $144.98M | $122.97M | $160.60M | $162.48M | $167.58M | $111.79M | $206.19M | $195.30M | $189.84M | $123.00M | $161.01M | $47.79M | $-917.79K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.72% | 0.74% | 0.57% | 0.21% | 0.45% | 0.67% | 0.96% | 0.93% | 0.93% | 1.05% | 1.30% | 0.99% | 2.92% | 44.24% |
Forecast
Align SG&A Forecast
Quarter
Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 9 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $401.64M | $407.99M | $453.19M | $439.69M | $410.07M | $398.55M | $426.40M | $439.46M | $451.19M | $428.41M | $431.92M | $397.12M | $348.39M | $312.49M | $256.97M |
Avg Forecast | $672.32M | $649.06M | $626.60M | $513.08M | $499.29M | $519.67M | $494.30M | $480.11M | $467.86M | $488.36M | $466.51M | $450.35M | $446.09M | $467.57M | $553.30M | $420.69M | $448.08M | $446.67M | $503.00M | $474.34M | $434.07M | $443.48M | $457.27M | $460.89M | $440.40M | $426.68M | $304.72M | $356.28M | $238.37M | $146.47M |
High Forecast | $687.84M | $664.04M | $641.06M | $524.92M | $510.81M | $531.67M | $505.71M | $491.18M | $478.65M | $499.63M | $475.66M | $456.21M | $447.07M | $468.12M | $663.96M | $423.64M | $453.51M | $456.98M | $603.60M | $569.20M | $434.07M | $443.48M | $548.73M | $460.89M | $440.40M | $426.68M | $365.66M | $356.28M | $238.37M | $146.47M |
Low Forecast | $648.05M | $625.62M | $603.97M | $494.55M | $481.26M | $500.91M | $476.45M | $462.77M | $450.96M | $470.73M | $452.79M | $445.15M | $445.11M | $467.01M | $442.64M | $419.07M | $440.83M | $430.54M | $402.40M | $379.47M | $434.07M | $443.48M | $365.82M | $460.89M | $440.40M | $426.68M | $243.77M | $356.28M | $238.37M | $146.47M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.91% | 1.01% | 0.87% | 0.86% | 0.92% | 0.96% | 0.96% | 0.98% | 0.97% | 1.01% | 1.30% | 0.98% | 1.31% | 1.75% |
Forecast
Align EPS Forecast
Quarter
Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 9 | 4 | 4 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.64 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | $1.44 | $1.71 | $2.42 | $2.29 | $2.53 | $2.54 | $2.02 | $1.77 | $-0.52 |
Avg Forecast | $2.58 | $2.55 | $2.27 | $3.06 | $2.86 | $2.86 | $2.54 | $2.75 | $2.54 | $2.62 | $2.29 | $2.46 | $2.31 | $2.34 | $1.97 | $2.18 | $2.26 | $2.03 | $1.69 | $1.53 | $2.16 | $2.23 | $2.30 | $2.74 | $2.60 | $2.52 | $2.02 | $2.14 | $0.64 | $-0.01 |
High Forecast | $2.66 | $2.63 | $2.34 | $3.16 | $2.94 | $2.95 | $2.62 | $2.83 | $2.62 | $2.69 | $2.54 | $2.50 | $2.32 | $2.35 | $1.97 | $2.23 | $2.31 | $2.10 | $1.74 | $1.57 | $2.16 | $2.23 | $2.30 | $2.74 | $2.60 | $2.52 | $2.02 | $2.14 | $0.64 | $-0.01 |
Low Forecast | $2.46 | $2.43 | $2.17 | $2.92 | $2.72 | $2.73 | $2.42 | $2.62 | $2.42 | $2.49 | $2.16 | $2.40 | $2.31 | $2.32 | $1.97 | $2.13 | $2.22 | $1.94 | $1.61 | $1.49 | $2.16 | $2.23 | $2.30 | $2.74 | $2.60 | $2.52 | $2.02 | $2.14 | $0.64 | $-0.01 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.70% | 0.72% | 0.67% | 0.35% | 0.43% | 0.65% | 0.74% | 0.88% | 0.88% | 1.00% | 1.26% | 0.94% | 2.79% | 42.62% |
Forecast
Align Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TMDX | TransMedics Group | $65.53 | $110.60 | 68.78% | Buy |
INMD | InMode | $17.41 | $26.00 | 49.34% | Hold |
TNDM | Tandem Diabetes Care | $36.36 | $51.71 | 42.22% | Buy |
INSP | Inspire Medical Systems | $189.99 | $256.00 | 34.74% | Buy |
DXCM | DexCom | $86.43 | $110.00 | 27.27% | Buy |
ALGN | Align | $224.45 | $252.00 | 12.27% | Buy |
SYK | Stryker | $391.07 | $413.17 | 5.65% | Buy |
EW | Edwards Lifesciences | $71.13 | $75.08 | 5.55% | Buy |
MDT | Medtronic | $91.41 | $95.18 | 4.12% | Hold |
PODD | Insulet | $277.11 | $268.00 | -3.29% | Buy |
BSX | Boston Scientific | $102.71 | $97.44 | -5.13% | Buy |
ABT | Abbott Laboratories | $127.86 | $119.10 | -6.85% | Buy |
PEN | Penumbra | $269.73 | $232.09 | -13.95% | Buy |
NARI | Inari Medical | $79.70 | $65.63 | -17.65% | Hold |